News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

NIH Funds Nine Anti-Microbial Resistance Diagnostic Projects to Deal with ‘Super Bugs’ and Give Clinical Laboratories New Diagnostic Tools to Improve Patient Care

Lab-on-a-chip technology could reduce the time needed to identify infection-causing bacteria and for physicians to prescribe correct antibiotics 

Pathology groups and medical laboratories may see their role in the patient-care process grow if researchers succeed in developing culture-independent diagnostic tools that quickly identify bacterial infections as well as pinpoint the antibiotics needed to treat them.

In the battle against antibiotic-resistant infections (AKA “super bugs”) the National Institutes of Health (NIH) is funding nine research projects aimed at thwarting the growing problem of life-threatening infections that no longer are controlled or killed by today’s arsenal of drugs.

Common Practices in Hospitals Leading to Super Bugs

Currently, when infections are suspected in hospitals or other settings where illness can quickly spread, samples are sent to a central medical laboratory where it may take up to three days to determine what germ is causing the infection. Because of that delay, physicians often prescribe broad-spectrum antibiotics based on a patient’s symptoms rather than lab test results, a practice that can lead to the growth of antibiotic-resistant microbes. (more…)

Fully Automated Molecular Diagnostic Solutions Find a Home in Hospital Laboratories

New Load-and-Walk-Away Systems Promise Rapid Turnaround Times and Multi-Target Testing


Laboratory Automation is one important reason why more community hospital laboratories and local pathology groups can now perform a growing menu of molecular diagnostic tests. Rapid innovations in automation technology now make it possible for even low-volume medical laboratories to perform molecular testing using highly-automated “load and walk away” molecular analyzers.

Pathologists and clinical laboratory managers may be surprised to learn that the market for these simple-to-use automated analyzers is actually becoming crowded. There are at least five companies that now make bench top automated nucleic acid testing systems. These systems are designed to enable medium and low volume labs to compete in the nucleic acid testing arena. It is one reason why the number of community hospital laboratories and local anatomic pathology group practices are establishing molecular testing programs.
(more…)

;